Clinical Trial Update: A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating tenofovir disoproxil fumarate in Asian-American adults with chronic hepatitis B has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2011-08-03